Screener
Viridian Therapeutics, Inc. VRDN Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Preferred stock, series A non-voting convertible preferred stock, $0.01 par value; 435,000 shares authorized; 133,191 and 134,864 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 60,432 | 61,188 |
| Preferred stock, series B non-voting convertible preferred stock, $0.01 par value; 500,000 shares authorized; 48,463 and 79,620 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 37,592 | 70,868 |
| Common stock, $0.01 par value; 200,000,000 shares authorized; 113,238,218 and 101,826,500 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 1,132 | 1,018 |
| Additional paid-in capital | 2,134,572 | 1,927,104 |
| Accumulated other comprehensive income (loss) | (1,153) | 447 |
| Accumulated deficit | (1,570,478) | (1,338,458) |
| Total stockholders’ equity | 662,097 | 722,167 |
| Total liabilities and stockholders’ equity | $1,097,233 | $899,418 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s total liabilities & equity?
- Viridian Therapeutics, Inc. (VRDN) reported total liabilities & equity of $1.1B in Q2 2026.
- How has Viridian Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Viridian Therapeutics, Inc.'s total liabilities & equity increased by 88.4% year-over-year, from $582.32M to $1.1B.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total liabilities & equity has grown at a 46.9% compound annual growth rate (CAGR), from $131.26M to $899.42M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Viridian Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude